Physician profile
Stephen F Eberwine
NPI 1285603886
$26,132.19
in general payments reported to CMS, 2019-2025
83 companies · $3,220 in 2025
The $3,220 reported for 2025 was more than what 75% of Hematology & Oncology providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,854 · 2020: $4,251 · 2021: $3,842 · 2022: $3,570 · 2023: $2,877 · 2024: $3,517 · 2025: $3,220.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,721 · Education: $894.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,720.64 |
| Education | $893.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celgene Corporation | $1,738.74 | 2019-2025 | Reblozyl, Pomalyst |
| Novartis Pharmaceuticals Corporation | $1,599.52 | 2019-2025 | Piqray, Kisqali |
| Merck Sharp & Dohme LLC | $1,332.54 | 2019-2025 | Keytruda, Lynparza, Welireg |
| Regeneron Healthcare Solutions, INC. | $1,290.88 | 2019-2025 | Libtayo |
| Astrazeneca Pharmaceuticals LP | $1,269.21 | 2019-2025 | Lynparza, Enhertu, Calquence |
| Pfizer INC. | $1,213.14 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $1,085.74 | 2019-2025 | Opdivo, Opdualag |
| Janssen Biotech, INC. | $1,075.30 | 2019-2025 | Darzalex, Rybrevant, Tecvayli |
| Seagen INC. | $1,019.59 | 2019-2025 | Padcev, Adcetris, Tukysa |
| Daiichi Sankyo INC. | $1,014.17 | 2019-2025 | Enhertu, Injectafer, Datroway |
| Genzyme Corporation | $951.14 | 2019-2025 | |
| Astellas Pharma US INC | $928.00 | 2020-2025 | Padcev, Xtandi, Vyloy |
| Genentech USA, INC. | $888.77 | 2019-2025 | Tecentriq, Polivy, Phesgo |
| Amgen INC. | $855.96 | 2019-2023 | Lumakras, Vectibix, Xgeva |
| Gilead Sciences, INC. | $810.60 | 2019-2025 | Trodelvy |
Show all 83 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $696.77 | 2019-2025 | |
| Incyte Corporation | $693.90 | 2019-2025 | Jakafi, Monjuvi |
| Pharmacyclics LLC, An Abbvie Company | $520.30 | 2019-2023 | Imbruvica, Epkinly |
| Alexion Pharmaceuticals, INC. | $401.87 | 2019-2025 | Ultomiris, Soliris |
| Covis Pharma Gmbh | $400.00 | 2021 | |
| Lilly USA, LLC | $378.73 | 2019-2025 | Jaypirca, Verzenio, Retevmo |
| Exelixis INC. | $339.63 | 2019-2025 | Cabometyx |
| Adaptive Biotechnologies Corporation | $336.12 | 2023-2025 | Clonoseq |
| Abbvie INC. | $328.95 | 2019-2025 | Venclexta |
| Boehringer Ingelheim Pharmaceuticals, INC. | $309.02 | 2019-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $266.88 | 2019-2025 | Alunbrig, Fruzaqla, Iclusig |
| Array Biopharma INC | $263.91 | 2019-2025 | Braftovi, Mektovi, Xalkori |
| Puma Biotechnology, INC. | $261.12 | 2019-2025 | |
| Glaxosmithkline, LLC. | $226.20 | 2020-2025 | Zejula, Blenrep, Ojjaara |
| Emd Serono, INC. | $216.40 | 2019-2025 | Tepmetko |
| Beigene USA, INC. | $201.95 | 2020-2025 | Brukinsa |
| Morphosys, US INC. | $177.49 | 2021-2023 | Monjuvi |
| Bayer Healthcare Pharmaceuticals INC. | $167.93 | 2019-2025 | |
| Acrotech Biopharma INC. | $161.69 | 2022-2025 | Beleodaq |
| Ipsen Biopharmaceuticals, INC | $145.40 | 2019-2025 | Onivyde, Somatuline Depot |
| Janssen Pharmaceuticals, INC | $140.38 | 2019-2021 | |
| Sobi, INC | $137.82 | 2023-2025 | |
| Clovis Oncology, INC. | $131.02 | 2019-2020 | |
| Blueprint Medicines Corporation | $127.57 | 2021-2025 | Ayvakit |
| Geron Corporation | $118.27 | 2025 | Rytelo |
| Servier Pharmaceuticals LLC | $111.76 | 2023-2025 | |
| Coherus Oncology, INC. | $104.53 | 2022-2024 | |
| Agios Pharmaceuticals, INC. | $91.90 | 2019-2023 | Pyrukynd |
| Genmab U.S., INC. | $86.45 | 2023-2025 | Tivdak, Epkinly |
| Aveo Pharmaceuticals, INC. | $81.89 | 2022-2025 | |
| Acceleron Pharma, INC. | $80.16 | 2020-2021 | |
| Pharmaessentia USA Corporation | $78.67 | 2022-2025 | Besremi |
| Jazz Pharmaceuticals INC. | $70.86 | 2021-2025 | |
| Kite Pharma, INC. | $68.70 | 2020-2025 | Yescarta |
| Rigel Pharmaceuticals, INC. | $63.80 | 2019-2025 | Gavreto, Tavalisse, Rezlidhia |
| Azurity Pharmaceuticals, INC. | $63.34 | 2024-2025 | Vivimusta |
| Dova Pharmaceuticals | $59.62 | 2019-2021 | |
| Pharmacosmos Therapeutics INC. | $59.31 | 2021-2025 | Monoferric |
| Tempus Ai, INC | $50.56 | 2024-2025 | Xt Cdx |
| Tesaro, INC. | $49.82 | 2019 | |
| Janssen Scientific Affairs, LLC | $48.17 | 2023-2024 | Rybrevant |
| Sanofi-Aventis U.S. LLC | $46.89 | 2021 | |
| Foundation Medicine, INC. | $39.80 | 2019-2023 | |
| Helsinn Therapeutics (U.S.), INC. | $39.48 | 2019-2022 | |
| Taiho Oncology, INC. | $39.16 | 2023-2024 | |
| Epizyme, INC. | $38.82 | 2020-2021 | |
| Teva Pharmaceuticals USA, INC. | $36.94 | 2019-2020 | |
| Adc Therapeutics America, INC. | $35.66 | 2023-2024 | |
| Caris Mpi, INC. | $35.43 | 2025 | Mi Cancer Seek |
| Octapharma USA, INC. | $35.27 | 2024 | Octagam Immune Globulin (Human) |
| Legend Biotech USA INC. | $34.64 | 2025 | Carvykti |
| Cti Biopharma Corp. | $33.19 | 2022-2023 | Vonjo |
| Stemline Therapeutics INC. | $29.95 | 2023 | Orserdu |
| Syndax Pharmaceuticals, INC. | $29.15 | 2025 | Revuforj |
| Global Blood Therapeutics, INC. | $27.38 | 2022 | |
| Sun Pharmaceutical Industries INC. | $24.16 | 2022 | |
| Sandoz INC. | $22.87 | 2019 | |
| Corcept Therapeutics | $22.43 | 2025 | Korlym |
| Immunomedics, INC. | $20.09 | 2020 | |
| Pharming Healthcare, INC. | $19.96 | 2023 | Ruconest |
| Aurobindo Pharma USA, INC. | $19.42 | 2019 | |
| Beone Medicines USA, INC. | $19.25 | 2025 | Brukinsa |
| Secura Bio, INC. | $18.01 | 2020 | |
| Karyopharm Therapeutics INC. | $17.69 | 2020 | |
| Verastem, INC. | $16.56 | 2020 | |
| Tg Therapeutics, INC. | $14.13 | 2021 | |
| Mirati Therapeutics, INC. | $12.80 | 2023 | Krazati |
| Mylan Institutional INC. | $10.90 | 2019 |
Drugs and devices associated with these payments
Keytruda $635Kisqali $452Trodelvy $441Lynparza $339Enhertu $337Clonoseq $336Lenvima $286Adcetris $275Elrexfio $249Padcev $247Reblozyl $240Opdivo $220Rybrevant $200Jakafi $170Darzalex $160Imbruvica $154Scemblix $146Sarclisa $145Piqray $141Xtandi $133Ibrance $132Beleodaq $124Epkinly $123Venclexta $120Rytelo $118Welireg $111Ayvakit $111Doptelet $110Braftovi $110Mektovi $110Brukinsa $103Lorbrena $101Tukysa $101Xalkori $98.26Monjuvi $93.95Cabometyx $91.55Tibsovo $90.98Zejula $89.75Ultomiris $87.27Jaypirca $85.38Tecvayli $84.92Verzenio $82.92Tecentriq $79.55Injectafer $77.83Alunbrig $77.74Libtayo $73.08Eliquis $72.93Bosulif $72.50Polivy $72.42Tivdak $71.14Jevtana $69.55Talvey $68.73Fabhalta $68.73Fotivda $68.12Paxlovid $66.18Talzenna $65.60Inlyta $65.24Vivimusta $63.34Udenyca $61.22Onivyde $56.11Fruzaqla $55.71Opdualag $55.66Pluvicto $51.82Soliris $49.99Comirnaty $49.64Phesgo $47.78Monoferric $46.40Datroway $44.09Vonjo $43.34Promacta $40.52Lonsurf $39.16Calquence $38.53Stivarga $38.46Vitrakvi $38.46Pomalyst $37.67Besremi $37.28Mi Cancer Seek $35.43Octagam Immune Globulin (Human) $35.27Carvykti $34.64Zepzelca $34.56Alecensa $33.36Rozlytrek $33.36Perjeta $32.95Orserdu $29.95Revuforj $29.15Tasigna $27.88Iclusig $27.03Besponsa $26.69Lumakras $26.38Wayrilz $26.01Somatuline Depot $24.82Yescarta $24.49Airsupra $23.50Rezlidhia $23.36Gavreto $23.36Tavalisse $23.36Nerlynx $23.07Korlym $22.43Xt Cdx $22.22Tafinlar $21.78
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Eberwine listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.